Penn State Health Milton S. Hershey Medical Center is a 628-bed non-profit, tertiary, research and academic medical center located in Hershey, Pennsylvania, servicing the Central Pennsylvania area. MSHMC is the region's only university-level academic medical center.

During the past decade, Penn State Milton S. Hershey Medical Center conducted 527 clinical trials. In the 10-year time frame, 527 clinical trials started and 362 clinical trials were completed, i.e. on average, 68.7% percent of trials that started reached the finish line to date. In the past 5 years, 198 clinical trials started and 192 clinical trials were completed. i.e. 97% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn State Milton S. Hershey Medical Center" #1 sponsor was "Milton S. Hershey Medical Center" with 226 trials, followed by "National Cancer Institute (NCI)" with 116 trials sponsored, "Gynecologic Oncology Group" with 40 trials sponsored, "Radiation Therapy Oncology Group" with 22 trials sponsored and "Penn State University" with 22 trials sponsored. Other sponsors include 688 different institutions and companies that sponsored additional 337 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State Milton S. Hershey Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 163 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Milton S. Hershey Medical Center" with 20 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 19 trials as a collaborator and "National Institutes of Health (NIH)" with 19 trials as a collaborator. Other collaborators include 568 different institutions and companies that were collaborators in the rest 339 trials.

According to Clinical.Site data, the most researched conditions in "Penn State Milton S. Hershey Medical Center" are "Cystic Fibrosis" (30 trials), "HIV Infections" (28 trials), "Heart Failure" (25 trials), "Breast Cancer" (22 trials) and "Ovarian Cancer" (20 trials). Many other conditions were trialed in "Penn State Milton S. Hershey Medical Center" in a lesser frequency.

Most popular intervention types in "Penn State Milton S. Hershey Medical Center" are "Drug" (716 trials), "Other" (250 trials), "Device" (126 trials), "Biological" (123 trials) and "Procedure" (113 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (125 trials), "Laboratory Biomarker Analysis" (91 trials), "Quality-of-Life Assessment" (46 trials), "Paclitaxel" (34 trials) and "Carboplatin" (29 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Milton S. Hershey Medical Center" are 957 trials for "All" genders, 128 trials for "Female" genders and 33 trials for "Male" genders.

Currently, there are 304 active trials in "Penn State Milton S. Hershey Medical Center". 3 are not yet recruiting, 142 are recruiting, 149 are Active, not recruiting, and 10 are Enrolling by invitation. In total, there were 624 completed trials in Penn State Milton S. Hershey Medical Center, 4 suspended trials, and 138 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Milton S. Hershey Medical Center, 95 "Phase 1" clinical trials were conducted, 317 "Phase 2" clinical trials and 352 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 59 trials, and there were also 215 trials that are defined as “Not Applicable".

Penn State Milton S. Hershey Medical Center has several departments that took part in Clinical trials: "Penn State Children's Hospital" - 172 trials, "Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases" - 6 trials, "Penn State Hershey Medical Center Department of Dermatology" - 4 trials, "Penn State Hershey Neurology" - 2 trials